HKSH Mobile App | Wechat Booking
Request an Appointment | Online Booking
What's New
Submitted by CADLanceCheung on 2018-12-03
2018-12-03
HKSH’s Exemplary Research Efforts in Theranostics World’s First Use of Dual-tracer (11C-Acetate and 18F-FDG) PET/CT in 90Y Selective Internal Radiation Therapy (SIRT) for Late-stage Liver Cancer
(3 December 2018 - Hong Kong) Hong Kong Sanatorium & Hospital (HKSH) has been committed to promoting medical research to optimise clinical applications for the benefit of patients. Recently, Department of Nuclear Medicine and PET and Comprehensive Oncology Centre of Hong Kong Sanatorium & Hospital joined efforts to have achieved fruitful results in the Selective Internal Radiation Therapy (SIRT) using Yittrium-90 (90Y) isotopes for Late-Stage Liver Cancer treatment. The research paper was recently published in the November issue of the European Journal of Nuclear Medicine and Molecular Imaging.
Please click here for more information.
Please click here for more information.
FRAUD ALERT: Reports have been received from the public about fraudulent calls impersonating Hong Kong Sanatorium & Hospital, falsely claiming uncollected medical documents. Do not respond or share personal information. Please be aware of bogus communications (fraudulent websites, emails and phone calls) purportedly from HKSH Medical Group or its members including Hong Kong Sanatorium & Hospital, HKSH Healthcare, HKSH Eastern Medical Centre, HKSH Cancer Centre and affiliates. Do not disclose any personal information to suspicious calls. Please call HKSH Medical Group at 2572 0211 if you have any concerns.
